Impact of ab-interno trabeculectomy on Bruch's membrane opening-based morphometry of the optic nerve head for glaucoma progression analysis.
Ablation Techniques
/ methods
Aged
Bruch Membrane
/ pathology
Disease Progression
Female
Follow-Up Studies
Glaucoma
/ diagnosis
Humans
Intraocular Pressure
/ physiology
Male
Optic Disk
/ pathology
Prognosis
Retrospective Studies
Tomography, Optical Coherence
/ methods
Trabeculectomy
/ methods
Visual Fields
/ physiology
Bruch’s membrane opening minimum rim width
Glaucoma progression analysis
Morphometry of the optic nerve head
Optical coherence tomography
Structural reversal of disc cupping
Journal
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
20
08
2018
accepted:
12
11
2018
revised:
18
10
2018
pubmed:
30
11
2018
medline:
20
2
2019
entrez:
29
11
2018
Statut:
ppublish
Résumé
To analyze the longitudinal change in Bruch's membrane opening minimal rim width (BMO-MRW) and circumpapillary retinal nerve fiber layer (RNFL) thickness using spectral domain optical coherence tomography (SD-OCT) after glaucoma surgery via ab-interno trabeculectomy in adult glaucoma patients. Retrospective audit of 65 eyes of 65 participants undergoing ab-interno trabeculectomy using electroablation of the trabecular meshwork. In 53 eyes, surgery was combined with phacoemulsification and posterior chamber lens implantation. Pre- and postoperative SD-OCT examinations of the optic nerve head (ONH), intraocular pressure (IOP), and visual field data were analyzed. Longitudinal change in morphometric SD-OCT parameters of the ONH was compared and correlated to change in IOP and visual field function. BMO-MRW increased significantly between baseline (BL) and follow-up (FU) within the first 6 months after surgery (BL = 167.85 ± 90 μm; FU = 175.59 ± 89 μm; p = 0.034). This increase correlated with postoperative lowering of IOP (rho = - 0.41; p = 0.016). Nine months after surgery (range, 7-12 months), there was no significant change in BMO-MRW (BL = 196.79 ± 79; FU = 196.47 ± 85 μm; p = 0.95), while in later follow-up, a decrease of BMO-MRW was found (BL = 175.18 ± 78; FU = 168.65 ± 72; p = 0.05). RNFL thickness was unchanged in early (p > 0.16) and significantly decreased in later follow-up (p = 0.009). Mean deviation (MD) of visual field function did not show a significant change before and after surgery. Electroablative ab-interno trabeculectomy leads to a significant transient mild increase in BMO-MRW. This increase was shown to correlate with IOP lowering. Significant loss of BMO-MRW in later follow-up may reflect insufficient IOP reduction by surgery. The parameters RNFL thickness and MD seem less impacted directly by surgery.
Identifiants
pubmed: 30483950
doi: 10.1007/s00417-018-4187-2
pii: 10.1007/s00417-018-4187-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
339-347Références
Ophthalmology. 1999 May;106(5):1013-8
pubmed: 10328406
Ophthalmology. 1999 Jun;106(6):1147-51
pubmed: 10366084
Br J Ophthalmol. 2001 Aug;85(8):956-61
pubmed: 11466255
J Glaucoma. 2001 Oct;10(5):369-82
pubmed: 11711833
Ophthalmology. 2005 Jun;112(6):962-7
pubmed: 15882909
J Glaucoma. 2006 Feb;15(1):68-73
pubmed: 16378021
J Cataract Refract Surg. 2008 Jul;34(7):1096-103
pubmed: 18571075
Trans Am Ophthalmol Soc. 2008;106:149-59; discussion 159-60
pubmed: 19277230
Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4719-26
pubmed: 19420342
Ophthalmology. 2011 Jan;118(1):52-9
pubmed: 20656352
Invest Ophthalmol Vis Sci. 2011 Mar 02;52(3):1206-19
pubmed: 21217108
Invest Ophthalmol Vis Sci. 2011 Dec 09;52(13):9431-7
pubmed: 22058335
Ophthalmology. 2012 Jul;119(7):1359-66
pubmed: 22464141
Ophthalmology. 2013 Mar;120(3):553-559
pubmed: 23218823
Ophthalmology. 2013 Mar;120(3):535-543
pubmed: 23265804
Am J Ophthalmol. 2013 Aug;156(2):218-227.e2
pubmed: 23768651
Invest Ophthalmol Vis Sci. 2014 May 02;55(5):2953-62
pubmed: 24692125
Br J Ophthalmol. 2015 May;99(5):599-603
pubmed: 25034049
Invest Ophthalmol Vis Sci. 2015 Jan 15;56(2):865-74
pubmed: 25593025
Ophthalmology. 2015 Sep;122(9):1786-94
pubmed: 26198806
Ophthalmology. 2015 Nov;122(11):2234-42
pubmed: 26298719
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6886-91
pubmed: 26501416
Ophthalmology. 2016 Jan;123(1):117-28
pubmed: 26602970
Graefes Arch Clin Exp Ophthalmol. 2016 Jun;254(6):1159-66
pubmed: 26995555
Br J Ophthalmol. 2017 Apr;101(4):530-535
pubmed: 27436783
Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6596-6603
pubmed: 27951592
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO20-BIO26
pubmed: 28475699
Br J Ophthalmol. 2018 Jan;102(1):131-135
pubmed: 28490427
Ophthalmology. 2017 Dec;124(12S):S57-S65
pubmed: 29157363
Acta Ophthalmol. 2019 Feb;97(1):60-67
pubmed: 29575745
Am J Ophthalmol. 2018 Oct;194:143-152
pubmed: 30053469
Am J Ophthalmol. 1996 Nov;122(5):690-5
pubmed: 8909209